AstraZeneca's George Kirk tells us the story of Koselugo – a treatment for the rare genetic condition neurofibromatosis 1.

Business insurance exists to help companies when unexpected events and damages occur – so you need to have the right policy in place.

EMA reviews lessons learned from nitrosamine impurities.

Llama antibodies may be crucial in the fight against COVID-19.

What makes pharma so good at rebranding?

An AI platform seeks out drugs that can be repurposed to treat COVID-19.

A position paper outlines why manufacturers must improve data integrity for excipients.

Improving productivity and efficiency with electronic records.

Is stencil printing a viable approach to create flexible dosage forms?

Researchers have identified four drugs capable of preventing preterm labor and birth.